| 0 (0%) | 11-11 15:55 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 18.92 | 1-year : | 22.1 |
| Resists | First : | 16.2 | Second : | 18.92 |
| Pivot price | 13.24 |
|||
| Supports | First : | 12.92 | Second : | 10.9 |
| MAs | MA(5) : | 14.69 |
MA(20) : | 12.84 |
| MA(100) : | 11.19 |
MA(250) : | 9.42 |
|
| MACD | MACD : | 0.8 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 75.2 |
D(3) : | 67.1 |
| RSI | RSI(14): 76.5 |
|||
| 52-week | High : | 16.2 | Low : | 6.55 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AUPH ] has closed below upper band by 3.3%. Bollinger Bands are 136% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 15.01 - 15.06 | 15.06 - 15.11 |
| Low: | 14.4 - 14.47 | 14.47 - 14.53 |
| Close: | 14.78 - 14.89 | 14.89 - 14.98 |
Tue, 11 Nov 2025
Aurinia Pharmaceuticals (NasdaqGM:AUPH): Valuation Insights Following Strong Q3 Results and Raised 2025 Guidance - simplywall.st
Mon, 10 Nov 2025
(AUPH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Sun, 09 Nov 2025
AUPH Dec 2025 15.000 call (AUPH251219C00015000) stock price, news, quote and history - Yahoo Finance UK
Sat, 08 Nov 2025
Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st
Fri, 07 Nov 2025
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Nasdaq
Fri, 07 Nov 2025
New Analyst Forecast: $AUPH Given $21.0 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 132 (M) |
| Held by Insiders | 1.2806e+008 (%) |
| Held by Institutions | 7.1 (%) |
| Shares Short | 8,980 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 66.69 |
| Profit Margin | 23.3 % |
| Operating Margin | 28.8 % |
| Return on Assets (ttm) | 7.6 % |
| Return on Equity (ttm) | 17.3 % |
| Qtrly Rev. Growth | 22.3 % |
| Gross Profit (p.s.) | 1.65484e+008 |
| Sales Per Share | 2.06437e+008 |
| EBITDA (p.s.) | 6.55397e+007 |
| Qtrly Earnings Growth | 3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 93 (M) |
| PE Ratio | 36.19 |
| PEG Ratio | 0 |
| Price to Book value | 0.23 |
| Price to Sales | 0 |
| Price to Cash Flow | 7.75 |
| Dividend | 0 |
| Forward Dividend | 8.39e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|